Longitude Capital Partners Iii, Llc - Net Worth and Insider Trading

Over the past 18 months, Longitude Capital Partners Iii, Llc made no insider transaction in Molecular Templates Inc (MTEM). Other recent insider transactions involving Molecular Templates Inc (MTEM) include a net purchase of 3,225,499 shares made by Biotech Target N V ,

In summary, during the past 3 months, insiders sold 1,279,820 shares of Molecular Templates Inc (MTEM) in total and bought 0 shares, with a net sale of 1,279,820 shares. During the past 18 months, 1,279,820 shares of Molecular Templates Inc (MTEM) were sold and 533,688 shares were bought by its insiders, resulting in a net sale of 746,132 shares.

Molecular Templates Inc (MTEM)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Longitude Capital Partners Iii, Llc made no insider transaction in Inozyme Pharma Inc (INZY). Other recent insider transactions involving Inozyme Pharma Inc (INZY) include a net purchase of 833,333 shares made by Robert Lorne Hopfner , a net purchase of 833,333 shares made by Pivotal Bioventure Partners Fund I G.p., L.p. , and a net sale of 7,523 shares made by Douglas A Treco .

In summary, during the past 3 months, insiders sold 0 shares of Inozyme Pharma Inc (INZY) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 7,523 shares of Inozyme Pharma Inc (INZY) were sold and 1,666,666 shares were bought by its insiders, resulting in a net purchase of 1,659,143 shares.

Inozyme Pharma Inc (INZY)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Longitude Capital Partners Iii, Llc made no insider transaction in 89bio Inc (ETNB). Other recent insider transactions involving 89bio Inc (ETNB) include a net sale of 42,195 shares made by Rohan Palekar , a net purchase of 1,350,000 shares made by Ra Capital Healthcare Fund Lp , and a net sale of 27,955 shares made by Quoc Le-nguyen .

In summary, during the past 3 months, insiders sold 27,955 shares of 89bio Inc (ETNB) in total and bought 25,000 shares, with a net sale of 2,955 shares. During the past 18 months, 97,650 shares of 89bio Inc (ETNB) were sold and 1,375,000 shares were bought by its insiders, resulting in a net purchase of 1,277,350 shares.

89bio Inc (ETNB)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Sierra Oncology Inc (SRRA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Sierra Oncology Inc (SRRA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Sierra Oncology Inc (SRRA)'s detailed insider trading history can be found in Insider Trading Tracker table.

Over the past 18 months, Longitude Capital Partners Iii, Llc made no insider transaction in Axonics Inc (AXNX). Other recent insider transactions involving Axonics Inc (AXNX) include a net sale of 35,287 shares made by Karen Noblett , a net sale of 32,884 shares made by Ford Alfred J Jr , and a net sale of 6,450 shares made by Kari Leigh Keese .

In summary, during the past 3 months, insiders sold 2,961 shares of Axonics Inc (AXNX) in total and bought 0 shares, with a net sale of 2,961 shares. During the past 18 months, 133,356 shares of Axonics Inc (AXNX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 133,356 shares.

Axonics Inc (AXNX)'s detailed insider trading history can be found in Insider Trading Tracker table.

In summary, during the past 3 months, insiders sold 0 shares of Talaris Therapeutics Inc (TALS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Talaris Therapeutics Inc (TALS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Talaris Therapeutics Inc (TALS)'s detailed insider trading history can be found in Insider Trading Tracker table.